pharmaceuticals Archives - Page 5 of 5

Strong 3Q of Sopharma indicates better than expected FY 2016

15 December 2016

Pharmaceuticals leader Sopharma booked a strong 3Q16 and is heading for a better than expected FY2016 performance. A new turning point for Sopharma After two years of disappointing performance due to heavy exposure to Russia and Ukraine, Sopharma’s latest results signal an inflection point into better times. 3Q16 top line and operating profitability improved considerably.… Read more

Sopharma net income up 30.4% in H1 2016 on divestments

29 July 2016

Sopharma books 30.4% y/y rise in net income to BGN 33.8m in H1 2016 on divestments

Sopharma Trading’s AGM approved BGN 0.30 DPS

21 June 2016

Sopharma Trading’s (SO5 BU) AGM approved BGN 0.30 DPS at the annual general meeting (AGM) held on June 17th 2016. This yields 5.39% at Friday’s close quotes. The ex-div day is June 29th, 2016. Expansion ahead Company’s CEO Dimitar Dimitrov said topline expansion in Serbia and pharmacy retail growth are the targets. He did not… Read more

Sopharma Q1 2016 net profit jumps 62% y/y

5 May 2016

Leading Bulgarian generic pharma producer Sopharma (3JR BU) books 62.3% y/y rise in net income, sales add 2.47% y/y as Ukraine stabilized. The company published individual Q1 2016 financial statements.

2015 for Sopharma was better than expected

9 February 2016

Sopharma (3JR BU) posts BGN 173m stand-alone revenues in FY2015, down 13.7% y/y. Results beat the estimates of ELANA Trading analysts and are in line with preliminary numbers announced by the company.

Pharmaceutical wholesaler Sopharma Trading – profitable Q3 and new pockets of growth

11 December 2015

Leading Bulgarian pharmaceutical wholesaler Sopharma Trading delivered excellent 9M 2015 results despite challenging environment, in a very competitive market. Sales were up 5% y/y to BGN 449.3 m.